CHMP roundup
May 24, 2011Sales and Marketing CHMP, EMA, Fampyra, Vibativ, Victrelis, Xgeva, Yervoy
The latest products to be recommended for European approval include MSD’s Victrelis, Astellas Pharma Europe’s Vibativ, Amgen Europe’s Xgeva and …
Pfizer and BMS to give Eliquis a rolling launch in Europe
May 24, 2011Sales and Marketing Eliquis, Pfizer, apixaban, atrial fibrillation
Pfizer and Bristol-Myers Squibb are gearing up to give their new oral anticoagulant Eliquis a rolling launch in Europe, starting …
Job cuts at AstraZeneca’s US manufacturing plant
May 24, 2011Manufacturing and Production AstraZeneca, job cuts
AstraZeneca says it will cut around 135 positions at its manufacturing facility in Westborough, Massachusetts, from the end of this …
Interpack 2011: new product showcase
May 24, 2011Manufacturing and Production Interpack, manufacturing and production
This year’s Interpack exhibition in Duesseldorf featured the usual crop of new product launches from processing and packaging equipment suppliers. …
Uptake of pharma chemicals by crops “an environmental concern”
May 24, 2011Manufacturing and Production manufacturing and production, pharma manufacturing
Chemicals which enter the environment in the wastewater of pharmaceutical production facilities can be taken up by crops and other …
Lilly cuts jobs in Ireland
May 23, 2011Manufacturing and Production Ireland, job cuts, lilly, manufacturing and production
Eli Lilly has said it is downsizing its plant in County Cork, Ireland, by around 14% in light of patent …
European recommendation for GSK’s lupus drug Benlysta
May 23, 2011Sales and Marketing Benlysta, CHMP, GlaxoSmithKline, Lupus
GlaxoSmithKline’s first-in-class lupus drug Benlysta has been given a major boost by regulators in the European Union. The European Medicines …
Pfizer and BMS’ blood thinner Eliquis approved in Europe
May 23, 2011Sales and Marketing BMS, Eliquis, Pfizer, apixaban
Pfizer and Bristol-Myers Squibb’s eagerly anticipated blood thinner Eliquis has gained European approval. A twice-daily oral Factor Xa inhibitor, Eliquis …
Lansley announces U-turn on cancer networks
May 23, 2011Cancer, NHS, NHS reforms
Health secretary Andrew Lansley has declared that cancer networks will be maintained, reversing an earlier decision to axe them. Lansley …
Nicola Miles joins MedeConnect
May 23, 2011Sales and Marketing appointment, sales and marketing
MedeConnect Healthcare Insight, the market research division of Doctors.net.uk, has strengthened its senior research team with the appointment of Nicola …
Pharma manufacturing investment in emerging markets
May 23, 2011Manufacturing and Production emerging marketing, pharma manufacturing
The pharmaceutical industry needs to undertake a radical overhaul in its approach to manufacturing which at present is ‘‘inefficient, underutilised …
Digital Pharma: Pfizer scores with football game
May 20, 2011Medical Communications Back In Play, Digital Pharma blog, ManMOT, Pfizer, digi game
Pfizer’s football-themed campaign to raise awareness of ankylosing spondylitis has picked up one of a brace of awards for the …
Sarah McKinnon Clark joins the Red Consultancy
May 20, 2011Medical Communications appointment, medical communications
The Red Consultancy has hired Sarah McKinnon Clark as an account manager for its specialist health team Red Health. She …
Shire promotional magnet attracts FDA wrath
May 20, 2011Medical Communications, Sales and Marketing FDA, Shire
The use of a promotional magnet by marketers at Shire has attracted trouble from the FDA. The magnet, which is …
GSK takes lead role in UK personalised medicine programme
May 20, 2011Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine
The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …
Pfizer’s cancer drug meets end points in head-to-head study
May 20, 2011Research and Development, Sales and Marketing Pfizer, axitinib, rcc
Pfizer’s investigational cancer drug axitinib significantly increased survival in kidney cancer patients when compared to Bayer’s standard treatment Nexavar. New …
Stephen Dorrell: Health reforms need wider focus
May 19, 2011Health and Social Care Bill, NHS reforms
The government’s radical reform of the NHS must focus on integrated care and not just GPs, according to the chairman …
Blood cancer charity to kick-start clinical trials
May 19, 2011Research and Development Cancer, blood cancer, clinical trials, leukaemia
A UK blood cancer charity is creating a network of clinical trial centres with backing from the NIHR Clinical Research …
MetMab produces exciting results in lung cancer patients
May 19, 2011Research and Development MetMAb, Roche
Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …
Takeda buys Nycomed for $13.6bn
May 19, 2011Manufacturing and Production, Research and Development, Sales and Marketing Nycomed, Takeda
Takeda has acquired Swiss specialist pharma firm Nycomed, boosting its presence in emerging markets. The deal comes in at 9.6 …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
